Navigation Links
Genomic surveillance of pandemic H1N1
Date:1/21/2010

VANCOUVER, B.C. The BC Centre for Disease Control has launched an influenza genome sequencing project to better understand how the pandemic H1N1 flu virus has evolved in British Columbia, and may continue to evolve in the coming months.

This project capitalizes on BC's expertise and capacity in genome sequencing to generate hundreds of complete genomes from circulating influenza viruses collected in British Columbia during the H1N1 pandemic, as well as during and after the Olympics. By comparing the evolution of BC's influenza virus to that of viruses sequenced in other regions, researchers hope to learn how a mass gathering such as the Olympics can impact the virus' genetic sequence. The project will also allow researchers to track the geographic origins of the H1N1 virus that entered BC in 2009.

"We know from earlier studies that one of the most important drivers of an influenza virus' evolution is the mixing of different lineages of virus from around the world," explains Dr. Robert Brunham, Provincial Executive Director of the BC Centre for Disease Control. "While we are not expecting a third wave of H1N1 in BC, we will have over 250,000 visitors in Vancouver in February, which may impact influenza virus evolution."

Although researchers predict that exposure to influenza viruses from different countries will lead to changes in the H1N1 virus' genetic sequence, these changes are unlikely to change the severity of disease due to the H1N1 virus.

"The data uncovered from this project will enable BC to track how the virus moved through the population - information that can assist public health officials in understanding the virus and preparing for future outbreaks," explains Dr. Perry Kendall, British Columbia's Provincial Health Officer.

Large-scale genome projects such as this have only become common in the last five years, as sequencing technologies have improved and become faster and more cost-efficient. "This is the first time since this technology has matured that both a pandemic and an Olympics have occurred together," says Dr. Alan Winter, President and CEO of Genome BC. "The timing provides a very significant opportunity to study how a virus evolves when it is meeting and mixing with viruses from around the world."

While influenza activity has declined to baseline or below baseline levels in Canada, pandemic H1N1 activity elsewhere remains variable, with some Eastern European and Western Asian countries continuing to report above-baseline activity levels.

This project is jointly funded by the BC Centre for Disease Control, Genome British Columbia and Genome Canada. Research is being conducted at both the BCCDC Public Health Microbiology & Reference Laboratory and Canada's Michael Smith Genome Sciences Centre.


'/>"/>

Contact: Gabrielle Nye
604-790-0034
Genome BC
Source:Eurekalert

Related medicine news :

1. The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
2. NeoGenomics Announces Executive Appointments
3. Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium
4. Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress
5. Will genomics help prevent the next pandemic?
6. Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
7. Genomic Health to Present at the JMP Securities Healthcare Focus Conference
8. Genomic Health to Present at Two Upcoming Investor Conferences
9. Beckman Coulter Announces the Creation of Beckman Coulter Genomics
10. Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference
11. GenVaults GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Florida (PRWEB) , ... February 05, 2016 , ... Steven ... event he has completed every year since it started in 2003. This year, he ... the attention of fellow runners and NBA team the Miami Heat. , This Sunday, ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... company's lighter, sleeker next generation LYNX VR Indoor Trainer with multi-rider capability to ... design and manufacturing not only reduce the weight of the unit, they also ...
(Date:2/5/2016)... ... 2016 , ... Successful recruitment and retention efforts, new collaborations ... have all marked the last 12 months at Roswell Park Cancer Institute (RPCI). ... oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of her ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular ... Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” campaign on ... muscular dystrophy, ALS and related diseases that severely limit strength and mobility. ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016 Amgen (NASDAQ: AMGN ) will present ... Conference at 9:15 a.m. ET on Wednesday, Feb. 10, 2016, ... W. Meline , executive vice president and chief financial officer ... the presentation can be accessed from the Events Calendar on ... the webcast will also be available on Amgen,s website for ...
(Date:2/5/2016)... Feb. 5, 2016  ivWatch, a medical devices company, is ... Award granted by Governor Terry McAuliffe,s office. ivWatch ... February 25th at an event to be held at the ... award honors professionals and business that have made significant contributions ... Logo - http://photos.prnewswire.com/prnh/20160205/330117LOGO ...
(Date:2/5/2016)... MILTON, Ontario , Feb. 5, 2016  Aralez ... business combination of POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada ... of POZEN and shareholders of Tribute. The combined company ... specialty pharmaceutical company with operations in Canada ... the United States . Under the terms ...
Breaking Medicine Technology: